Janssen Biotech
Bristol-Myers Squibb
Novartis
Celgene
Kesios Therapeutics
Amgen
Sanofi Genzyme
Juno Therapeutics
Takeda
Karyopharm etc.
Published | Pages | Publisher | Report code |
---|---|---|---|
Jul 2020 | 204 | MarkNtel Advisors | ASDR-547422 |
Janssen Biotech
Bristol-Myers Squibb
Novartis
Celgene
Kesios Therapeutics
Amgen
Sanofi Genzyme
Juno Therapeutics
Takeda
Karyopharm etc.